content_top
43 companies, 1 interpreter! Insight, foresight
and recommendation 

Intrexon Corporation (XON)

19.85
0.00
(0.00%)
Sep 11, 4:02PM EDT
content_middle

Intrexon Corporation through a suite of proprietary and complementary technologies, designs, builds, and regulates gene programs, which are DNA sequences that consist of key genetic components. Its technologies include UltraVector gene design and fabrication platform, and its associated library of modular DNA components; cell systems informatics; RheoSwitch inducible gene switch; AttSite Recombinases; protein engineering; mAbLogix; and laser-enabled analysis and processing. Intrexon Corporation has collaboration agreements with ZIOPHARM Oncology, Inc.; Synthetic Biologics, Inc.; Oragenics, Inc.; Fibrocell Science, Inc.; Genopaver, LLC; AquaBounty Technologies, Inc.; S & I Ophthalmic, LLC; Biological & Popular Culture, Inc.; OvaXon, LLC; Intrexon Energy Partners, LLC; and Persea Bio, LLC; and strategic collaboration and licensing agreement with Merck Serono S.A. The company was formerly known as Genomatix Ltd. and changed its name to Intrexon Corporation in 2005. Intrexon Corporation was founded in 1998 and is based in Germantown, Maryland.

Previous Close: 
19.85
Open: 
20.07
Bid: 
19.20
Ask: 
20.25
1yr Target Price: 
38.50
Day's Range: 
19.64 - 20.25
52wk Range: 
17.03 - 32.90
Volume: 
612637
Average Daily Volume: 
884570
Market Capitalization: 
2.39B
Trailing Annual Dividend Yield: 
N/A
Shares Outstanding: 
120519000M
content_right